CALU A29809G polymorphism in coronary atherothrombosis: Implications for coronary calcification and prognosis

References

• Ross R. Atherosclerosis-an inflammatory disease. N Engl J Med. 1999;340:115–26.
   PubMed Web of Science ®Google Scholar
• Tousoulis D, Davies G, Stefanadis C, Toutouzas P, Ambrose JA. Inflammatory and thrombotic mechanisms in coronary atherosclerosis. Heart. 2003;89:993–7.
   PubMed Web of Science ®Google Scholar
• Falk E. Pathogenesis of atherosclerosis. J Am Coll Cardiol. 2006;47 Suppl 8:C7–12.
   PubMed Web of Science ®Google Scholar
• Cheng GC, Loree HM, Kamm RD, Lee RT. Distribution of circumferential stress in ruptured and stable atherosclerotic lesions. A structural analysis with histopathological correlation. Circulation. 1993;87:1179–87.
   PubMed Web of Science ®Google Scholar
• Wexler L, Brundage B, Crouse J, Detrano R, Fuster V, Maddahi J, . Coronary artery calcification: pathophysiology, epidemiology, imaging methods, and clinical implications. A statement for heath professional from the American Heart Association. Circulation. 1996;94:1175–92.
   PubMed Web of Science ®Google Scholar
• Tanimura A, McGregor DH, Anderson HC. Calcification in atherosclerosis, I: human studies. J Exp Pathol. 1986;2: 261–73.
   PubMedGoogle Scholar
• Massberg S, Brand K, Gruner S, Page S, Müller E, Müller I, . A critical role of platelet adhesion in the initiation of atherosclerotic lesion formation. J Exp Med. 2002;196: 887–96.
   PubMed Web of Science ®Google Scholar
• Coppinger JA, Cagney G, Toomey S, Kislinger T, Belton O, McRedmond JP, . Characterization of the proteins released from activated platelets leads to localization of novel platelet proteins in human atherosclerotic lesions. Blood. 2004;103:2096–104.
   PubMed Web of Science ®Google Scholar
• Jung DH, Mo SH, Kim DH. Calumenin, a multiple EF-hands Ca2+-binding protein, interacts with ryanodine receptor-1 in rabbit skeletal sarcoplasmic reticulum. Biochem Biophys Res Comm. 2006;343:34–42.
   PubMed Web of Science ®Google Scholar
• Honoré B. The rapidly expanding CREC protein family: members, localization, function, and role in disease. BioEssays. 2009;31:262–77.
   PubMed Web of Science ®Google Scholar
• Wajih N, Sane DC, Hutson SM, Tallin R. The inhibitory effect of calumenin on the vitamin K-dependent γ-carboxylation system. Characterization of the system in normal and warfarin-resistant rats. J Biol Chem. 2004;24: 25279–83.
   Google Scholar
• Furie B, Furie BC. Molecular basis of vitamin K-dependent gamma-carboxylation. Blood. 1990;75:1753–62.
   PubMed Web of Science ®Google Scholar
• Hansen GA, Vorum H, Jacobsen C, Honoré B. Calumenin but not reticulocalbin forms a Ca+2-dependent complex with thrombospondin-1. A potential role in haemostasis and thrombosis. Moll Cell Biochem. 2009;320:25–33.
   PubMed Web of Science ®Google Scholar
• Kimura R, Kokubo Y, Miyashita K, Otsubo R, Nagatsuka K, Otsuki T, . Polymorphisms in vitamin K-dependent gamma-carboxylationrelated genes influence interindividual variability in plasma protein C and protein S activities in the general population. Int J Hematol. 2006;84:387–97.
   PubMed Web of Science ®Google Scholar
• González-Conejero R, Corral J, Roldán V, Ferrer F, Sánchez-Serrano I, Sánchez-Blanco JJ, . The genetic interaction between VKORC1 c1173t and calumenin a29809g modulates the anticoagulant response of acenocoumarol. J Throm Haemost. 2007;5:1701–6.
   PubMed Web of Science ®Google Scholar
• Vecsler M, Loebstein R, Almog S, Kurnik D, Goldman B, Halkin H, . Combined genetic profiles of components and regulators of the vitamin K-dependent gamma-carboxylation system affect individual sensitivity to warfarin. Thromb Haemost. 2006;95:205–11.
   PubMed Web of Science ®Google Scholar
• Lip GY, Blann AD. Thrombogenesis, atherogenesis and angiogenesis in vascular disease: a new ‘vascular triad’. Ann Med. 2004;36:119–25.
   PubMed Web of Science ®Google Scholar
• Bertrand ME, Simoons ML, Fox KA, Wallentin LC, Hamm CW, McFadden E, . Task Force on Management of Acute Coronary Syndromes of the European Society of Cardiology. Management of acute coronary syndromes in patients presenting without persistent ST-segment elevation. Eur Heart J. 2002;23:1809–40.
   PubMed Web of Science ®Google Scholar
• Tuzcu EM, Berkalp B, De Franco A, Ellis SG, Goormastic M, Whitlow PL, . The dilemma of diagnosing coronary calcification: angiography versus intravascular ultrasound. J Am Coll Cardiol. 1996;27:832–8.
   PubMed Web of Science ®Google Scholar
• Tello-Montoliu A, Marín F, Roldán V, Mainar L, López MT, Sogorb F, . A multimarker risk stratification approach to non-ST elevation acute coronary syndrome: implications of troponin T, CRP, NT pro-BNP and fibrin D-dimer levels. J Int Med. 2007;262:651–8.
   PubMed Web of Science ®Google Scholar
• Greenland P, Bonow RO, Brundage BH, Budoff MJ, Eisenberg MJ, Grundy SM, . ACCF/AHA 2007 clinical expert consensus document on coronary artery calcium scoring by computed tomography in global cardiovascular risk assessment and in evaluation of patients with chest pain: a report of the American College of Cardiology Foundation Clinical Expert Consensus Task Force (ACCF/AHA Writing Committee to Update the 2000 Expert Consensus Document on Electron Beam Computed Tomography). J Am Coll Cardiol. 2007;49:378–402.
   PubMed Web of Science ®Google Scholar
• Johnson RC, Leopold LA, Loscalzo J. Vascular calcification: pathobiological mechanisms and clinical implications. Circ Res. 2006;99:1044–59.
   PubMed Web of Science ®Google Scholar
• Abdullah SM, Khera A, Das SR, Stanek HG, Canham RM, Chung AK, . Relation of coronary atherosclerosis determined by electron beam computed tomography and plasma levels of N-terminal pro-brain natriuretic peptide in a multiethnic population-based sample (The Dallas Heart Study). Am J Cardiol. 2005;96:1284–9.
   PubMed Web of Science ®Google Scholar
• Østergaard M, Hansen GA, Vorum H, Honoré B. Proteomic profiling of fibroblasts reveals a modulating effect of extracellular calumenin on the organization of the actin cytoskeleton. Proteomics. 2006;6:3509–19.
   PubMed Web of Science ®Google Scholar
• Zebboudj AF, Imura M, Boström K. Matrix gla protein, a regulatory protein for bone morphogenetic protein-2. J Biol Chem. 2002;277:4388–94.
   PubMed Web of Science ®Google Scholar
• Newman B, Gigout LI, Sudre L, Grant ME, Wallis GA. Coordinated expression of matrix Gla protein is required during endochondral ossification for chondrocyte survival. J Cell Biol. 2001;154:659–66.
   PubMed Web of Science ®Google Scholar
• Calumenin polymorphisms, last accessed 15-Jan-2010. Available at: http://hapmap.ncbi.nlm.nih.gov/.
   Google Scholar
• Pesole G, Grillo G, Larizza A, Liuni S. The untranslated regions of eukaryotic mRNAs: Structure, function, evolution and bioinformatic tools for their analysis. Brief Bioinform. 2000;1:236–49.
   PubMedGoogle Scholar
• Lindahl B, Toss H, Siegbahn A, Venge P, Wallentin L. for the FIRSC Study Group. Markers of myocardial damage and inflammation in relation to long-term mortality in unstable coronary artery disease. J Am Coll Cardiol. 1997;29:43–8.
   PubMed Web of Science ®Google Scholar
• Sabatine MS, Morrow DA, de Lemos JA, Gibson M, Murphy SA, Rifaiet N, . Multimarker approach to risk stratification in non-ST elevation acute coronary syndromes. Simultaneous assessment of troponin-I, C-reactive protein, and B-type natriuretic peptide. Circulation. 2002;105:1760–3.
   PubMed Web of Science ®Google Scholar
• Eggers KM, Lagerqvist B, Venge P, Wallentin L, Lindahl B. Prognostic value of biomarkers during and after non-ST-segment elevation acute coronary syndrome. J Am Coll C-*ardiol. 2009;54:357–64.
   PubMed Web of Science ®Google Scholar
• Schurgers LJ, Aebert H, Vermeer C, Bültmann B Janzen J. Oral anticoagulant treatment: friend or foe in cardiovascular disease? Blood. 2004;104:3231–2.
   PubMed Web of Science ®Google Scholar